Last reviewed · How we verify
NCT04218214: LIFE-DM
Mixed Methods Implementation Evaluation of an Integrated Depression and Microfinance Program for Women in Vietnam
trial testing LIFE-DM Group (Integrated Depression and Livelihood Group Intervention) in Depression in 141 participants. Completed in 31 March 2019.
31 December 2018
Quick facts
| Lead sponsor | RAND |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 141 |
| Start date | 7 December 2017 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 March 2019 |
| Sites | 2 locations across Vietnam |
Drugs / interventions tested
- LIFE-DM Group (Integrated Depression and Livelihood Group Intervention)
Conditions studied
- Depression — all drugs for Depression →
Sponsor
RAND — full company profile →
Who can join
Adults 18 to 60, female only, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an implementation project to develop a model to support implementation of LIFE-DM, an evidence-based practice (EBP) program that integrates depression management with microfinance services to address both poverty and depression among low-income women in Vietnam. This evaluation is a mixed methods study that will 1) describe the development of community-partnered implementation process, 2) study the effectiveness of the training and implementation support plan on provider and patient outcomes, and 3) identify factors that impact implementation success.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04218214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other RAND trials
Trials by the same sponsor.
- NCT06048328 — Game Changers for Family Planning Peer Advocacy Program · Phase 1, PHASE2 · not yet recruiting
- NCT07072819 — Pilot of Training on 988 and Narcan · NA · completed
- NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting
- NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
- NCT06827288 — Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04218214 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RAND
- Last refreshed: 6 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04218214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing